2 brilliant growth and income stocks I’d buy today

These two stocks could deliver excellent total returns over the long term.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

3i Infrastructure (LSE: 3IN) released a first-half trading update today, telling us that “the portfolio overall continues to perform in line with expectations.” Chairman Richard Laing said the board is particularly pleased with the “strong level of income.” He added: “We remain on track to deliver a full year dividend of 7.85p per share.”

The shares opened about a penny higher at 195p, valuing the FTSE 250 firm at just over £2bn and presenting investors with a prospective dividend yield of 4%.

Long-term yield and capital growth

3i said cash inflows for the six months to 30 September totalled £80.6m, compared with £55.7m in the previous six months to 31 March, and £44.7m in the six months to 30 September 2016.

The company’s cash flows and record of steadily increasing dividends reflect its strategy of investing in operating businesses and projects that generate long-term yield and capital growth. The focus is on economic infrastructure and greenfield projects in developed economies, principally in Europe.

Looking ahead, management said today: “We are reviewing several opportunities to deploy follow-on capital in existing portfolio companies as well as potential new investments in the company’s target markets.” With a cash balance of £40m and undrawn borrowing facilities of £349m out of £500m available, 3i has more than adequate liquidity to further its investments.

This bodes well for a continuation of a rewarding history for shareholders from a company that sports an annualised total return of 11.7% over the last 10 years and an annualised net asset value return of 10.5% over the same period. It’s a stock I’d happily buy for the long term.

Neat low-risk business model

Also falling into this category is speciality pharmaceuticals firm Alliance Pharma (LSE: APH). The company is run by industry veterans and has a neat low-risk business model. Its expertise lies in the acquisition and licensing of pharmaceutical and healthcare products carefully selected for a blend of underlying sales stability and growth potential. Capital-intensive activities, such as manufacturing, warehousing and logistics are outsourced.

Founded in 1996 and floated in 2003, Alliance’s revenue is set to break through £100m this year. At a share price of 55p, this AIM-listed company is valued at £261m. It trades on 13.8 times current-year forecast earnings per share (EPS) of 4p, with a well-covered forecast dividend of 1.28p giving a yield of 2.3%. For next year, the earnings multiple falls to 12.2 on forecast EPS of 4.5p and the dividend yield rises to 2.6% on a forecasted payout of 1.45p.

The valuation looks highly attractive to me and I wouldn’t be surprised if the company beats expectations. Looking ahead, it said in its half-year results earlier this month: “With the integration of the Sinclair Pharma products now complete we are strategically positioned for growth and, with leverage levels reducing, we are now able to pursue bolt-on acquisitions.”

Alliance boasts an annualised total return of 21.7% over the last 10 years and I fully expect this well-managed business to go on delivering excellent value for its shareholders. As such, this is another stock I’d be happy to buy today for the long term.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

G A Chester has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Affectionate Asian senior mother and daughter using smartphone together at home, smiling joyfully
Investing Articles

How I’d invest my first £20k ISA to target £4,900 a year from dividend shares

Looking for dividend shares in a new Stocks and Shares ISA, and want diversification too? Here's how I'd go about…

Read more »

Passive income text with pin graph chart on business table
Investing Articles

Yields of up to 7%! I’d consider boosting my income with these FTSE dividend stocks

The London market has some decent-looking dividend stocks right now, and I’m tempted by these two for growing income streams.

Read more »

Young mixed-race couple sat on the beach looking out over the sea
Investing Articles

I’d put £20K in an ISA now to target a £1,900 monthly second income in future!

Christopher Ruane shares why he thinks a long-term approach to investing and careful selection of shares could help him build…

Read more »

Mature couple at the beach
Investing Articles

6 stocks that Fools have been buying!

Our Foolish freelancers are putting their money where their mouths are and buying these stocks in recent weeks.

Read more »

Black woman using loudspeaker to be heard
Investing Articles

I was right about the Barclays share price! Here’s what I think happens next

Jon Smith explains why he still feels the Barclays share price is undervalued and flags up why updates on its…

Read more »

Investing Articles

Where I’d start investing £8,000 in April 2024

Writer Ben McPoland highlights two areas of the stock market that he would target if he were to start investing…

Read more »

View of Tower Bridge in Autumn
Investing Articles

Ahead of the ISA deadline, here are 3 FTSE 100 stocks I’d consider

Jon Smith notes down some FTSE 100 stocks in sectors ranging from property to retail that he thinks could offer…

Read more »

Young female business analyst looking at a graph chart while working from home
Investing Articles

Why I think Rolls-Royce shares will pay a dividend in 2024

Stephen Wright thinks Rolls-Royce shares are about to pay a dividend again. But he isn’t convinced this is something investors…

Read more »